Statistics for Merck & (id:8477 MRK)

Valuation metrics

Market cap

244.26B

Enterprise value

267.23B

Trailing P/E (ttm)

20.20

Forward P/E

10.27

PEG ratio

10.27

Price/Sales (ttm)

3.87

Price/Book (mrq)

5.49

Enterprise Value/Revenue

4.23

Enterprise Value/EBITDA

11.66

Overview

Shares outstanding

2.53B

Float

2.53B

Shares short

26.23M

% Held by insiders

0.00%

% Held by institutions

0.79%

Average volume (10 days)

9.98M

Average volume (90 days)

Price summary

52-Week low

94.48

52-Week high

134.63

52-Week change

-4.55%

Beta

0.41

50-Day moving average

108.84

200-Day moving average

121.05

Dividends and splits

Forward annual dividend rate

3.08

Forward annual dividend yield

0.03

Trailing annual dividend rate

3.04%

Trailing annual dividend yield

0.03

5-Year annual dividend yield

2.90

Payout ratio

0.64

Dividend date

October 07th, 2024

Ex-dividend date

September 16th, 2024

Last split factor

2:1

Last split date

June 03th, 2021

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

19.23%

Operating margin

26.20%

Operational effectiveness

Return on assets

10.53%

Return on equity

28.33%

Income statement

Revenue (ttm)

24.93

Revenue per share (ttm)

24.93

Quarterly revenue growth (yoy)

-0.34

Gross profit (ttm)

43.99B

EBITDA

7.54B

Net income to common (ttm)

12.15B

Diluted EPS (ttm)

4.78

Quarterly earnings growth (yoy)

-33.50%

Balance sheet

Total cash (mrq)

14.59B

Total cash per share (mrq)

5.77

Total debt (mrq)

38.13B

Total Debt/Equity (mrq)

85.57

Current ratio (mrq)

136.40%

Book value per share (mrq)

17.58

Cash flow

Cash flow statement

18.26B

Levered free cash flow (LFCF)

14.02B